Pravastatin for prevention of HELLP syndrome: A case report

    loading  Checking for direct PDF access through Ovid

Abstract

Rationale:

Pravastatin has emerged for prevention and treatment of preeclampsia; no reports are available on pravastatin and HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome.

Patient concerns:

The first pregnancy necessitated termination of pregnancy at gestational age (GA) 20+5 for HELLP. Intrauterine fetal death at GA 22+5 occurred in the second pregnancy, whilst on temporizing management of HELLP.

Diagnoses:

Severe, recurrent early-onset HELLP syndrome.

Interventions:

In her fourth pregnancy, pravastatin was commenced at GA 13.

Outcomes:

The course of pregnancy was uncomplicated, and a healthy, appropriate for gestational age fetus was delivered at term.

Lessons:

Pravastatin may be effective in prevention of HELLP. The hepatic uptake may be of particular advantage.

Related Topics

    loading  Loading Related Articles